#AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, has signed anoth...
OSLO, Norway: #AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, has signed another license contract with existing smartphone customer Transsion. This contract encompasses the usage of Elliptic Labs’ AI Virtual Proximity Sensor™ INNER BEAUTY® for several future smartphone deployments.
"It’s exciting that Transsion continues to deploy our AI Virtual Proximity Sensor on their smartphones," said Laila Danielsen, CEO of Elliptic Labs. "Collaborating with Transsion brings the AI Virtual Smart Sensor Platform™ to their latest smartphone designs. Together with Transsion we deliver devices that are greener, smarter, and more human-friendly."
INNER BEAUTY is a registered trademark of Elliptic Labs.
AI Virtual Smart Sensor, AI Virtual Proximity Sensor, and AI Virtual Smart Sensor Platform are trademarks of Elliptic Labs.
All other trademarks or service marks are the responsibility of their respective organizations.
AI Virtual Proximity Sensor INNER BEAUTY
Elliptic Labs’ AI Virtual Proximity Sensor detects when a user holds their phone up to their ear during a call, allowing the smartphone to turn off its display and disable its screen’s touch functionality. This keeps the user’s ear or cheek from triggering unwanted actions during the call, such as hanging up or dialing numbers. Turning off the screen also helps conserve battery life.
Proximity detection is a core capability that is used in all smartphones, but Elliptic Labs’ AI Virtual Proximity Sensor is a unique, software-only solution that delivers robust proximity detection without the need for a dedicated hardware sensor. By replacing hardware sensors with software sensors, the AI Virtual Proximity Sensor reduces device cost and eliminates sourcing risk.
About Elliptic Labs
Elliptic Labs is a global enterprise targeting the smartphone, laptop, IoT, and automotive markets. Founded in 2006 as a research spin-off from Norway’s Oslo University, the company’s patented software uses AI, ultrasound and sensor fusion to deliver intuitive 3D gesture, proximity-, presence-, breathing- and heartbeat-detection experiences. Its scalable AI Virtual Smart Sensor Platform creates software-only sensors that are sustainable, human-friendly and already deployed in hundreds of millions of devices around the world. Elliptic Labs is the only software company that has delivered detection capabilities using AI software, ultrasound, and sensor fusion deployed at scale. The company joined the Oslo Børs main listing in March 2022.
Elliptic Labs is headquartered in Norway with presence in the USA, China, South Korea, Taiwan, and Japan. Its technology and IP are developed in Norway and are solely owned by the company.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
#AI--Keysight Technologies, Inc. (NYSE: KEYS) launched AppFusion, a network visibility partner program that integrates third-party security and monitoring…
#AI--AI-powered solutions for addressing visual impairments, optimizing brands for AI search and creating AI agents won the ISG Startup Challenges at…
Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), continues its mission of building smarter, more…
N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. (“Syapse”),…